EPS for Brighthouse Financial, Inc. (BHF) Expected At $2.10; Eam Investors Has Lowered Esperion Therapeutics (ESPR) Position

April 17, 2018 - By Marie Mckinney

Analysts expect Brighthouse Financial, Inc. (NASDAQ:BHF) to report $2.10 EPS on May, 7 after the close.BHF’s profit would be $251.50 million giving it 6.06 P/E if the $2.10 EPS is correct. After having $0.37 EPS previously, Brighthouse Financial, Inc.’s analysts see 467.57% EPS growth. The stock increased 0.67% or $0.34 during the last trading session, reaching $50.9. About 155,881 shares traded. Brighthouse Financial, Inc. (NASDAQ:BHF) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Eam Investors Llc decreased Esperion Therapeutics Inc. (ESPR) stake by 7.91% reported in 2017Q4 SEC filing. Eam Investors Llc sold 7,351 shares as Esperion Therapeutics Inc. (ESPR)’s stock rose 22.41%. The Eam Investors Llc holds 85,548 shares with $5.63M value, down from 92,899 last quarter. Esperion Therapeutics Inc. now has $2.01 billion valuation. The stock increased 1.99% or $1.48 during the last trading session, reaching $75.97. About 206,165 shares traded. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 89.86% since April 17, 2017 and is uptrending. It has outperformed by 78.31% the S&P500.

Investors sentiment decreased to 1.33 in 2017 Q4. Its down 0.34, from 1.67 in 2017Q3. It fall, as 19 investors sold ESPR shares while 39 reduced holdings. 33 funds opened positions while 44 raised stakes. 22.69 million shares or 0.18% less from 22.73 million shares in 2017Q3 were reported. Iguana Mngmt Lc reported 165,000 shares. Two Sigma Ltd Liability Co holds 5,191 shares or 0.01% of its portfolio. Atika Mgmt Lc reported 56,000 shares. Moreover, Ny State Common Retirement Fund has 0.01% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 70,272 shares. Invesco Limited stated it has 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Eam Invsts Ltd Llc holds 85,548 shares. Price T Rowe Associates Inc Md reported 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). One Trading Limited Partnership stated it has 4,841 shares. Quantitative Invest Limited Liability Company holds 0.02% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 17,000 shares. Swiss Bancorporation owns 34,300 shares. Efg Asset Management (Americas) Corp has invested 0.3% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Vanguard Gp stated it has 930,481 shares or 0% of all its holdings. Principal Gp Inc accumulated 4,169 shares. Rhenman And Prtnrs Asset Mngmt Ab has invested 3.44% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Moreover, Bb&T Secs Limited Liability Corp has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 4,000 shares.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Esperion Therapeutics had 61 analyst reports since July 28, 2015 according to SRatingsIntel. On Monday, March 19 the stock rating was maintained by Jefferies with “Buy”. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Buy” rating given on Wednesday, June 29 by Lake Street. UBS maintained it with “Neutral” rating and $90 target in Wednesday, February 21 report. The stock has “Buy” rating by Needham on Wednesday, October 18. Stifel Nicolaus maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) rating on Monday, June 26. Stifel Nicolaus has “Buy” rating and $6000 target. The company was maintained on Wednesday, August 9 by Deutsche Bank. Cowen & Co maintained the stock with “Buy” rating in Wednesday, October 18 report. The rating was maintained by Needham with “Buy” on Thursday, June 30. JP Morgan maintained it with “Neutral” rating and $65 target in Wednesday, February 21 report. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Outperform” rating by RBC Capital Markets on Friday, November 6.

Eam Investors Llc increased Vaneck Vectors Etf Trust stake by 54,685 shares to 624,178 valued at $42.33M in 2017Q4. It also upped Tabula Rasa Healthcare Inc. stake by 31,596 shares and now owns 178,588 shares. Ichor Holdings Ltd was raised too.

Analysts await Esperion Therapeutics, Inc. (NASDAQ:ESPR) to report earnings on May, 3. They expect $-1.56 EPS, up 13.33% or $0.24 from last year’s $-1.8 per share. After $-1.44 actual EPS reported by Esperion Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 8.33% negative EPS growth.

Among 7 analysts covering Brighthouse Financial (NASDAQ:BHF), 1 have Buy rating, 0 Sell and 6 Hold. Therefore 14% are positive. Brighthouse Financial had 9 analyst reports since August 8, 2017 according to SRatingsIntel. Argus Research initiated Brighthouse Financial, Inc. (NASDAQ:BHF) on Thursday, September 21 with “Hold” rating. The company was initiated on Tuesday, September 5 by Sandler O’Neill. The rating was maintained by RBC Capital Markets on Thursday, October 12 with “Hold”. The company was maintained on Monday, September 11 by RBC Capital Markets. The stock of Brighthouse Financial, Inc. (NASDAQ:BHF) earned “Hold” rating by RBC Capital Markets on Friday, November 3. Bank of America upgraded it to “Hold” rating and $63.0 target in Friday, September 8 report.

Brighthouse Financial, Inc. provides life insurance and annuity solutions in the United States. The company has market cap of $6.10 billion. It offers shield, variable, guaranteed income builder, income, and fixed annuities; and permanent and term life insurance products. It currently has negative earnings. The firm was incorporated in 2016 and is based in Charlotte, North Carolina.

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>